Health

Cancer immunotherapy may self-limit its efficacy in fighting tumors, study finds – News-Medical.net

Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy…

Published

4 years ago

June 23, 2021

Noosa Online News Publisher

Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy in fighting tumors, according to a new study led by Francesco Marangoni, Ph.D., assistant professor of physiology & biophysics…

Click here to view the original article.

Related Topics:Australia News-Medical.Net

Up Next

Switching to a balanced diet restores gut health and suppresses skin inflammation – News-Medical.Net

Don't Miss

Please take all COVID safe measures as the Ministry would not want a worst case scenario where they pull back to the hospitals to look after the increasing severe cases – Dr Fong – Fijivillage